|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$14.48 |
$14.63 |
$14.35 |
$14.48 |
520.60K | 04/18/2024 |
$14.49 |
$14.71 |
$14.44 |
$14.69 |
636.40K | 04/19/2024 |
$14.69 |
$15.02 |
$14.69 |
$14.95 |
635.90K | 04/22/2024 |
$14.98 |
$15.16 |
$14.83 |
$14.93 |
777.10K | 04/23/2024 |
$14.95 |
$15.35 |
$14.89 |
$15.17 |
1.49M |
|
Innoviva is a company with a portfolio of royalties and other healthcare assets. Co.'s royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and TRELEGY® ELLIPTA®. Co. is entitled to royalty payments made by GSK under its agreements that assigned to Theravance Respiratory Company, LLC (TRC), including TRELEGY® ELLIPTA® and any other product or combination of products that may be discovered or developed in the future under the Long-Acting Beta2 Agonist Collaboration Agreement and the Strategic Alliance Agreement with GSK, which have been assigned to TRC other than RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. | |
|
Innoviva (INVA) has the following price history information. Looking back at INVA historical stock prices for the last five trading days, on April 17, 2024, INVA opened at $14.48, traded as high as $14.63 and as low as $14.35, and closed at $14.48. Trading volume was a total of 520.60K shares. On April 18, 2024, INVA opened at $14.49, traded as high as $14.71 and as low as $14.44, and closed at $14.69. Trading volume was a total of 636.40K shares. On April 19, 2024, INVA opened at $14.69, traded as high as $15.02 and as low as $14.69, and closed at $14.95. Trading volume was a total of 635.90K shares. On April 22, 2024, INVA opened at $14.98, traded as high as $15.16 and as low as $14.83, and closed at $14.93. Trading volume was a total of 777.10K shares. On April 23, 2024, INVA opened at $14.95, traded as high as $15.35 and as low as $14.89, and closed at $15.17. Trading volume was a total of 1.49M shares.
INVA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Innoviva shares, starting with a $10,000 purchase of INVA, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$26.26 |
|
End price/share: |
$15.17 |
|
Starting shares: |
380.81 |
|
Ending shares: |
409.67 |
|
Dividends reinvested/share: |
$1.25 |
|
Total return: |
-37.85% |
|
Average Annual Total Return: |
-4.64% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,217.36 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$26.26 |
|
End price/share: |
$15.17 |
|
Dividends collected/share: |
$1.25 |
|
Total return: |
-37.47% |
|
Average Annual Total Return: |
-4.59% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,250.04 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/17/2024 | $14.48 | 04/18/2024 | $14.69 | 04/19/2024 | $14.95 | 04/22/2024 | $14.93 | 04/23/2024 | $15.17 |
|
|